Pre-Clinical

Woo JH, Li DP, Wilsbach K, Orita H, Coulter J, Tully E, Kwon TK, Xu S, and Gabrielson E. Coix Seed Extract, a Commonly Used Treatment for Cancer in China, Inhibits NFκB and Protein Kinase C Signalling. Cancer Biology and Therapy. 2007; accepted for publication.

Yuan, YZ, Bao Y, Xia L, Zhang YP, and Zhang XJ. A cDNA Microarray Study of the effect of Kanglaite Injection in Inducing Apopotosis of PATU-8988 Pancreatic Cancer Cells. Chinese Journal of Digestive Study. 2004;24:451-3

Clinical

Deng, SG, Wen SB, and Chen AL. Clinical observation of Kanglaite Injection Combined with Gemzar and Carboplatin in the Treatment of Mid and Late Stage NSCLC. Zhejiang Practical Medicine 2006;11:234-6

Wheeler RH, Busby L, Samlowski W, Gerard R, and Farling H. Phase I Study of Kanglaite Injection (KLT), a Botanical Product based on Chinese Medicine. Proceedings of ASCO 2003; Abstr 990

Busby LT, Jing J, Samlowski WE, McGregor JR, Farling H, and Wheeler RH. Phase I and Pharmacokinetic Study of Kanglaite Injection (KLT), a Botanical Product based on Traditional Chinese Medicine. Proceedings of ASCO 2002; Abstr 2192

Cui CX, Li JL, Hao XZ, Chu DT, and Wang JW.  A Clinical Observation of Kanglaite Injection in Combination with PVM Scheme in Treating Intermediate and Late Stage NSCLC. Qi Lu Journal of Oncology. 1997;4: 310-11; report of Phase III study